On this page
What makes a DTC television advertisement review package usable?
Establish the actual review basis, then provide matching clean and annotated storyboards, current labeling and applicable support. Represent spoken words, displayed text, imagery and timing together. Check the finished advertisement against the clear, conspicuous and neutral major-statement standards where applicable. A correct static transcript cannot establish that risk information is understandable in the actual audio and video.
Before you begin
Preparation of a prescription-drug television-ad review package. Determine whether the request is voluntary, subject to product-specific presubmission conditions or covered by an actual agency requirement. A television format alone does not settle the route.
What you will prepare: A versioned storyboard and supporting package with the true review basis and unresolved presentation questions identified.
Name the actual review basis
Obtain the agency notice or product conditions if review is said to be required. Otherwise establish the voluntary request being made under the applicable guidance. The March 2012 program document is draft; do not cite it as if every TV ad automatically has the same binding submission deadline. If the basis is unknown, stop short of a timing conclusion and resolve it with the regulatory owner.
Represent the viewer’s full experience
For a voluntary TV advisory package, IV.C.2 describes a clean and annotated storyboard, current labeling and appropriate supporting documentation. Show spoken words, on-screen text, imagery, scene sequence and timing together. If a video or animatic is included, match its version to the storyboard. Identify factual testimonial and translation support where applicable; do not fabricate a signed patient or translator statement.
Check the major statement in the finished advertisement
The CCN standards apply to consumer-directed human prescription-drug TV/radio ads naming the drug and its use; the compliance date was November 20, 2024. Check understandable consumer language and audio clarity at least equal to the rest of the ad. TV needs synchronized spoken and displayed risk information: verbatim key phrases or the full transcript, with enough reading time. Check type, contrast and placement for readability. Remove or revise elements likely to impede comprehension; this is not a categorical ban on music. Review the actual rendered video against these criteria, not just an annotated storyboard. Record unresolved defects and re-review the changed rendition.
Fictional example: the edit changes the message
The clean storyboard and the rendered video use the same words, but the final edit shortens the risk segment while introducing distracting visuals. Return the actual rendition for review and update the evidence package. If the ad switches languages, assess the complete translated spoken and visual presentation rather than substituting translated text into the old review record.
Review the timed presentation, not just its words
Use a scene record to connect the proposed storyboard with the actual audiovisual rendition. Preserve the exact version and language; a later edit can change the impression without changing the transcript.
| Scene record | Capture | Review question |
|---|---|---|
| Timing | Start/end of scene, spoken segment and corresponding text | Does displayed risk information accompany its audio for sufficient reading time? |
| Spoken content | Exact words and source support | Is the consumer meaning clear and appropriately supported? |
| On-screen text | Exact wording, placement, size, contrast and duration | Are key terms verbatim from the corresponding audio rather than synonyms? |
| Audio presentation | Volume, articulation, pacing and other sound | Is the major statement at least as understandable as the rest of the advertisement? |
| Visual presentation | Images, motion, transitions and simultaneous messages | Are elements likely to interfere with comprehension of the major statement? |
| Artifact identity | Storyboard, annotations, optional animatic/video and final rendition | Do all reviewed versions show the same intended presentation? |
For applicable consumer-directed prescription-drug TV/radio ads naming the drug and its use, the CCN standards address consumer-friendly language, audio understandability and interfering elements. Television also has concurrent audio/text and text-readability standards. The rule does not impose a universal reading-grade score or a single safe word-per-second threshold. Do not invent one to produce a pass/fail result.
Fictional rendition exercise: the storyboard shows a risk phrase during its spoken segment, but the final edit moves the text to the next scene after that audio ends. The words are unchanged, yet the synchronization needs correction. Identify the exact timecodes, revise the rendered file and recheck the entire major-statement segment for timing, readability and interference. Approval of the old storyboard is not evidence about the new edit.
Guidance IV.C.2 recommends clean and annotated storyboards for voluntary TV advisory review and permits an optional video or animatic in an acceptable format. It also describes applicable support for a person represented as an actual patient or health-care professional and an accurate foreign-language translation, including the respective signed statements. Obtain actual records; an actor release or an unsigned translation does not establish those specific facts.
The March 2012 pre-dissemination program document remains identified as draft in this guide. It is not a universal mandate for every television ad. Verify any actual agency notice or product-specific presubmission condition before stating a required review timeline. Use advisory preparation for voluntary requests and accelerated presubmission where applicable. Keep unrelated promotional pieces out of the TV advisory package.
Your preparation checklist
0/3 checkedUse this to track your review in this visit. Checks are not saved and do not establish regulatory compliance.
Frequently asked questions
Must the television text repeat every word of the spoken major statement?
The standard permits either verbatim key terms or phrases from the corresponding audio or the verbatim full transcript, with sufficient display duration and the required concurrent presentation. Synonyms are not the same as verbatim key terms. Review the actual timing, readability and meaning rather than counting identical words alone.
Is background music categorically prohibited during the major statement?
The standard addresses audio or visual elements, alone or together, likely to interfere with comprehension. It is not a categorical prohibition on all music. Assess the actual sound, visuals and presentation, and ensure that the major-statement audio is at least as understandable as the advertisement’s other audio information.
Can a storyboard alone prove that the final television advertisement meets the CCN standards?
No. A storyboard can support draft review, but the final rendition determines audio pacing, synchronization, text duration, contrast and potentially distracting effects. Reconcile the version and inspect the actual completed advertisement. An edit that preserves the transcript can still change the presentation materially.
Is a video mandatory in every voluntary TV advisory package?
Guidance IV.C.2 describes clean and annotated storyboards and applicable labeling and support, with video or animatic inclusion optional for that voluntary process. If included, use an acceptable format and matching version. Separately establish any specific agency request or product condition; optional draft-review video does not remove final-rendition review needs.
Sources and revisions
Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.
Guidance
FDA: Submissions of Promotional Labeling and Advertising ↗April 2022 final, Revision 1; IV.A–J, VI.E–H and VII. PDF production/PRA update April 2023 does not change the cover revision. Its legacy backbone syntax is not an eCTD v4 implementation guide. Checked September 22, 2026.
Guidance
FDA: DTC Prescription Drug Advertisements: Major Statement Final Rule Q&A ↗December 2023 final small-entity compliance guidance; Q1–9 explain 21 CFR 202.1(e)(1)(ii). Compliance date November 20, 2024. Reopened September 22, 2026.
Draft guidance
FDA draft: FDAAA DTC Television Ad Pre-Dissemination Review Program ↗March 2012 DRAFT cover inspected September 22, 2026. Not treated as a final universal submission mandate; actual notice and current legal basis must be verified for the product.
Technical specification · placement only
FDA eCTD v4.0 comprehensive hierarchy ↗Version 2.2, February 2025. Section 1.15.1.5. A heading identifies placement, not mandatory applicability.

